Documentation Centre

photo
February 14, 2019
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (HARMONY outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018;392:1519-1529
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators

Description of this Publication


Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Clinical Trials, Diabetes